The United States Department of Transportation, Office of the Secretary published a Notice of Review of Guidance in the Federal Register on February 2, 2019 which invites comments by April 8th. https://www.govinfo.gov/content/pkg/FR-2019-02-05/pdf/2019-01065.pdf https://www.federalregister.gov/documents/2019/02/05/2019-01065/notice-of-review-of-guidance
SUMMARY: The U.S. Department of Transportation (Department or DOT) is reviewing its existing guidance documents to evaluate their continued necessity and determine whether they need to be updated or revised. As part of this review, the Department invites the public to identify and provide input on existing guidance documents that are good candidates for repeal, replacement, or modification. In addition, the Federal Motor Carrier Safety Administration (FMCSA) will publish a separate notice in the Federal Register inviting public comment on specific actions that FMCSA would like to take on FMCSA guidance documents dealing with commercial drivers’ licenses.
DATES: Comments should be received on or before April 8, 2019. Late-filed comments will be considered to the extent practicable. ADDRESSES: You may file comments identified by the docket number [insert number] by any of the following methods: • Federal eRulemaking Portal: Go to http://www.regulations.gov and follow the online instructions for submitting comments.
Mail: Docket Management Facility, U.S. Department of Transportation, 1200 New Jersey Ave. SE, Room W12–140, Washington, DC 20590–0001. • Hand Delivery or Courier: The Docket Management Facility is located on the West Building, Ground Floor, of the U.S. Department of Transportation, 1200 New Jersey Ave. SE, Room W12– 140, between 9 a.m. and 5 p.m., Monday through Friday, except Federal holidays. Fax: 202–493–2251.
Instructions: You must include the agency name and the Docket Number DOT–OST–2017–0069 at the beginning of your comment. All comments received will be posted without change to http://www.regulations.gov, including any personal information provided.
Privacy Act: In accordance with 5 U.S.C. 553(c), DOT solicits comments from the public to better inform its rulemaking process. DOT posts these comments, without edit, to www.regulations.gov, as described in the system of records notice, DOT/ALL– 14 FDMS, accessible through www.dot.gov/privacy. In order to facilitate comment tracking and response, we encourage commenters to provide their name, or the name of their organization; however, submission of names is completely optional. Whether or not commenters identify themselves, all timely comments will be fully considered. If you wish to provide comments containing proprietary or confidential information, please contact the agency for alternate submission instructions. Docket: For access to the docket to read background documents or comments received, go to http:// www.regulations.gov or to the street address listed above. Follow the online instructions for accessing the docket.
FOR FURTHER INFORMATION CONTACT: Jonathan Moss, Assistant General Counsel for Regulation, U.S. Department of Transportation, 1200 New Jersey Ave. SE, Washington, DC 20590, 202–366– 4723 (phone), jonathan.moss@dot.gov (email).
https://www.federalregister.gov/documents/2019/02/05/2019-01065/notice-of-review-of-guidance
First Advantage has become aware that there is particular interest in comments on the following documents relative to whether the guidance document is: 1) no longer necessary; 2) spurs cost-inducing action by the regulated entities, 3) is inconsistent or unclear, 4) may not be conducive to uniform or consistent enforcement, or 5) needs to be updated to reflect developments, such as technological changes, that have taken place since the guidance was issued.
- Urine Specimen Collection Guidelines
- Substance Abuse Professional Guidelines
- What Employers Need to Know About DOT Drug and Alcohol Testing
- What Employers Need to Know About Monitoring Collection Sites
- What Employees Need to Know About DOT Drug and Alcohol Testing
- DOT’s “Recreational Marijuana” Notice
- DOT’s “Medical Marijuana” Notice
